In overweight or obese patients without diabetes mellitus, patients treated with GLP-1 RAs had significantly reduced major adverse cardiovascular events, all-cause death, myocardial infarction, and revascularization when compared with placebo [36] [37] [38]
As with any drug, its important to think about both the possible benefits and risks
Keywords: cobalamin, cat, methylmalonic acid 1
Ristori MV, Mortera SL, Marzano V, Guerrera S, Vernocchi P, Ianiro G, Gardini S, Torre G, Valeri G, Vicari S, Gasbarrini A, Putignani L (2020) Proteomics and metabolomics approaches towards a functional insight onto AUTISM spectrum disorders: phenotype stratification and biomarker discovery
WHO-GMP Certified Injectable Manufacturing Facility Advanced sterile manufacturing ensuring product safety and efficacy